Literature DB >> 9207790

A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins.

S H Cross1, R R Meehan, X Nan, A Bird.   

Abstract

Methylation of cytosines within the sequence CpG is essential for mouse development and has been linked to transcriptional suppression in vertebrate systems. Methyl-CpG binding proteins (MeCPs) 1 and 2 bind preferentially to methylated DNA and can inhibit transcription. The gene for MeCP2 has been cloned and a methyl-CpG binding domain (MBD) within it has been defined. A search of DNA sequence databases with the MBD sequence identified a human cDNA with potential to encode an MBD-like region. Sequencing of the complete cDNA revealed that the open reading frame also encodes two cysteine-rich domains that are found in animal DNA methyltransferases (DNMTs) and in the mammalian HRX protein (also known as MLL and All-1). HRX is related to Drosophila trithorax. The protein, known as Protein Containing MBD (PCM1), was expressed in bacteria and shown to bind specifically to methylated DNA. PCM1 also repressed transcription in vitro in a methylation-dependent manner. A polyclonal antibody raised against the protein was able to 'supershift' the native MeCP11 complex from HeLa cells, indicating that PCM1 is a component of mammalian MeCP1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207790     DOI: 10.1038/ng0797-256

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  67 in total

1.  Active repression of methylated genes by the chromosomal protein MBD1.

Authors:  H H Ng; P Jeppesen; A Bird
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1.

Authors:  A Bellacosa; L Cicchillitti; F Schepis; A Riccio; A T Yeung; Y Matsumoto; E A Golemis; M Genuardi; G Neri
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Methylation-dependent silencing at the H19 imprinting control region by MeCP2.

Authors:  Robert A Drewell; Carolyn J Goddard; Jean O Thomas; M Azim Surani
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

4.  The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation.

Authors:  Marco Birke; Silke Schreiner; María-Paz García-Cuéllar; Kerstin Mahr; Fritz Titgemeyer; Robert K Slany
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

5.  Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription.

Authors:  F Fuks; W A Burgers; N Godin; M Kasai; T Kouzarides
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

6.  Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator.

Authors:  J Chen; K Ueda; S Sakakibara; T Okuno; C Parravicini; M Corbellino; K Yamanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

7.  Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development.

Authors:  B Hendrich; J Guy; B Ramsahoye; V A Wilson; A Bird
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

8.  A sensitive mass spectrometry method for simultaneous quantification of DNA methylation and hydroxymethylation levels in biological samples.

Authors:  Thuc Le; Kee-Pyo Kim; Guoping Fan; Kym F Faull
Journal:  Anal Biochem       Date:  2011-01-24       Impact factor: 3.365

9.  Rds3p is required for stable U2 snRNP recruitment to the splicing apparatus.

Authors:  Qiang Wang; Brian C Rymond
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated.

Authors:  S Kudo
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.